CD163 and chronic kidney disease: We subsequently generated feature plots for healthy, AKI, and CKD groups to visualize AIF1 transcripts and quantified the percentage of AIF1-expressing cells among all CD163+ MΦs and monocytes/MΦs in each group (Figure 8C).